Commentary · 28 Feb 2025
Research articlePublished 29 Sep 2017
Preventive Treatment with Diclofenac Suppositories May Improve BCG Induced Cystitis Symptoms without Affecting Its Oncologic Efficacy: A Prospective Double Blind Randomized Trial
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Purpose: To evaluate whether prophylactic treatment with Diclofenac suppositories may relief bladder irritative symptoms following BCG irrigation, and to assess its effect on the oncologic outcome. Methods: A prospective, randomized, double-blind, placebo-control trial on 36 patients diagnosed with Non- Muscle Invasive Bladder Cancer (NMIBC) treated with induction installations of BCG. Patients received either a transrectal Diclofenac suppository (50 mg) or a placebo suppository immediately prior to and 24 hours after bladder irrigation. Following each irrigation patients completed a Quality of Life and a specific side effect questionnaire. Patients were thereafter followed prospectively for tumor recurrence. Results: For each irrigation, patients in the treatment group had statistically significant lower complains of dysuria (presented as the percent change from baseline; 473% vs. 161% in the control and treatment groups respectively, p=0.026). Other BCG side effects affected by the suppositories are reported. During a mean follow up of 22.8 month, 56% and 58% of patients in the treatment and control groups respectively had tumor recurrence (p=0.96). No significant side effects have been observed related to the study drug. Conclusion: Diclofenac suppositories are easy and safe to use and according to our results on this small study cohort, their use may suggest a beneficial effect in preventing complains caused by BCG induced cystitis without increasing tumor recurrence rate.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical Medicine and Therapeutics.
Opinion · 28 Feb 2025
Integrating Telemedicine into Chronic Disease Management
Short communication · 28 Feb 2025
Emerging Drug Therapies for Resistant Hypertension
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Medicine and Therapeutics
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Gal Rinott Mizrahi”
- BylineArticles whose byline prints “Avi Stein”
- BylineArticles whose byline prints “Boris Friedman”
- BylineArticles whose byline prints “Yuval Freifeld”
- BylineArticles whose byline prints “Yael Hod”
- BylineArticles whose byline prints “Yoram Dekel”
